DEFR14A: Cineverse Amends Director Compensation Plan Details
Proxy Statement Amendment
Cineverse Corp. filed an amendment to its proxy statement, clarifying director compensation limits and awards for its upcoming 2025 Annual Meeting of Stockholders.
Summary
- Cineverse Corp. filed Amendment No. 2 to its definitive proxy statement for the 2025 Annual Meeting of Stockholders scheduled for November 20, 2025.
- The amendment specifically modifies sentences within 'Proposal Four Amendment to 2017 Equity Incentive Plan to Increase the Total Number of Shares of Class A Common Stock Available for Issuance Thereunder'.
- The cap on aggregate non-employee director compensation under the 2017 Plan has been amended to $1,000,000 in value per year.
- It is anticipated that each non-employee director will receive a restricted stock award valued at $90,000 following each annual meeting, based on the trailing 20-day volume weighted average price (VWAP) of the Class A Common Stock.
- The anticipated non-employee director restricted stock award is independent of the approval of Proposal Four.
Sentiment
Score: 5
Explanation: The filing is a neutral clarification of existing proxy statement details regarding director compensation, without indicating significant positive or negative operational or financial performance.
Positives
- The amendment clarifies and formalizes a cap on aggregate non-employee director compensation at $1,000,000 in value per year, which is explicitly stated as a 'Key Feature and Governance Best Practice'.
Future Outlook
The company anticipates that each non-employee director will receive a restricted stock award valued at $90,000 following the date of each annual meeting of stockholders, based on the trailing 20-day volume weighted average price (VWAP) of the Class A Common Stock.
Industry Context
This filing is a routine amendment to a proxy statement, focusing on internal corporate governance related to director compensation. It does not provide information directly related to broader industry trends or competitive positioning.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to 2017 Equity Incentive Plan | Revised the cap on the aggregate value of shares of Common Stock that may be issued to all non-employee directors in any year to $1,000,000. Clarified that each non-employee director is anticipated to receive a restricted stock award valued at $90,000 annually, based on trailing 20-day VWAP, irrespective of Proposal Four approval. | N/A (clarification for existing plan, effective upon stockholder approval of Proposal Four for the plan itself) | Enhances transparency and formalizes limits on director compensation, aligning with stated governance best practices. Provides clarity on anticipated director awards. |
Stakeholder Impact
- Shareholders: Will vote on Proposal Four, which includes the amended terms for the 2017 Equity Incentive Plan and director compensation. The clarification provides more precise information for their voting decision.
Next Steps
- The 2025 Annual Meeting of Stockholders is scheduled for November 20, 2025, where Proposal Four, related to the Equity Incentive Plan, will be considered.
Key Dates
| Date | Description |
|---|---|
| 2025-10-10 | Cineverse Corp. filed its definitive proxy statement for the 2025 Annual Meeting of Stockholders. |
| 2025-10-14 | Amendment No. 1 to the Proxy Statement was filed, solely to include interactive data. |
| 2025-11-20 | Scheduled date for the 2025 Annual Meeting of Stockholders. |
Keywords
Cineverse, Proxy Statement, Director Compensation, Equity Incentive Plan, Corporate Governance, SEC Filing, DEFR14A, Stockholders Meeting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.